Chunk Public (all visitors)

Novavax - a Leading Vaccine candidate for COVID19 Coronavirus

PHARMACEUTICAL INDUSTRYACADEMIC RESEARCHMEDICINE

All tags · 5

PHARMACEUTICAL INDUSTRYACADEMIC RESEARCHMEDICINEHEALTHCAREBIOLOGY

Details

Owner: FoundryBase App
Visibility: Public (all visitors)
Resources: 2 resources
Created: Jan 29, 2021
Updated: Jan 23, 2025

Resources · 2

Filters

Article 2020

Novavax Gets $1.6 Billion for Coronavirus Vaccine From Operation Warp Speed - New York Times

The Maryland-based company, which has never brought a product to market before, just made the biggest deal to date with the Trump administration’s ...

Saved by FoundryBase 1 chunk

Article 2021

Covid-19: Novavax vaccine shows 89% efficacy in UK trials - BBC News

The Novavax jab is the first to show in trials that it is effective against the UK variant of the virus.

Saved by FoundryBase 1 chunk

Create

Start your own chunk.

Create a chunk

Novavax - a Leading Vaccine candidate for COVID19 Coronavirus

Resources · 2

Novavax Gets $1.6 Billion for Coronavirus Vaccine From Operation Warp Speed - New York Times

Covid-19: Novavax vaccine shows 89% efficacy in UK trials - BBC News

Related chunks

Start your own chunk.